French seniors asked about CBD: what do they know?
NCT ID NCT06094582
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study surveyed 47 older adults (65+) at a frailty clinic in France to learn about their use and understanding of cannabidiol (CBD). The goal was to gather information to help guide safe CBD use and prevent potential side effects in this age group. No treatment was given; it was purely a knowledge-gathering study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Toulouse
Toulouse, 31059, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart sensors at home could spot frailty early and lend a helping hand
- Could your heart hold the key to Alzheimer's prevention?
- The aging Body's hidden water shift: a new study investigates
- Can surgery for stomach or esophageal cancer cloud the mind?
- Rewiring the veteran brain: could visual training counteract cognitive decline?
- Can a simple walk test reveal hidden health risks in aging?